Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND BUB1B, BUBR1, 701, ENSG00000156970, SSK1, BUB1beta, MAD3L, hBUBR1, Bub1A, O60566 AND Prognosis
34 results:

  • 1. Impact of prognostic nutritional index change on prognosis after colorectal cancer surgery under propofol or sevoflurane anesthesia.
    Zhang L; Liu C; Yan Q; Cai X
    BMC Anesthesiol; 2024 Jan; 24(1):12. PubMed ID: 38172695
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Prognostic effect of preoperative Controlling Nutritional Status score in patients with locally advanced rectal cancer: A two-center, retrospective study.
    Lu S; Chen Z; Peng R; Zhang Q; Wang Y; Li X; Qu R; Zhou X; Fu W; Sun T; Wang H
    Nutrition; 2023 Aug; 112():112078. PubMed ID: 37267656
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The Diagnostic and Prognostic Value of miR-155 in cancers: An Updated Meta-analysis.
    Wu Y; Hong Q; Lu F; Zhang Z; Li J; Nie Z; He B
    Mol Diagn Ther; 2023 May; 27(3):283-301. PubMed ID: 36939982
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Outcomes of subjects who are lean, overweight or obese with nonalcoholic fatty liver disease: A cohort study in China.
    Lan Y; Lu Y; Li J; Hu S; Chen S; Wang Y; Yuan X; Liu H; Wang X; Wu S; Wang L
    Hepatol Commun; 2022 Dec; 6(12):3393-3405. PubMed ID: 36281973
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Identification of microsatellite instability and immune-related prognostic biomarkers in colon adenocarcinoma.
    Sun Z; Li G; Shang D; Zhang J; Ai L; Liu M
    Front Immunol; 2022; 13():988303. PubMed ID: 36275690
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. prognosis of mucinous colon cancer is determined by histological biomarkers rather than microsatellite instability.
    van Zwam PH; Vink-Börger EM; Bronkhorst CM; de Bruine AP; van der Wurff AA; Rutten HJT; Lemmens VEPP; Nagtegaal ID; Hugen N
    Histopathology; 2023 Jan; 82(2):314-323. PubMed ID: 36217248
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. NudCD1 as a prognostic marker in colorectal cancer and its role in the upregulation of cellular spindle assembly checkpoint genes and LIS1 pathways.
    Feng WM; Gong H; Wang YC; Wang Y; Xue T; Zhang T; Cui G
    BMC Cancer; 2022 Sep; 22(1):981. PubMed ID: 36104662
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Comparison of oncological outcomes between low anterior resection and abdominoperineal resection for rectal cancer: A retrospective cohort study using a multicenter database in Japan.
    Nagano H; Kajitani R; Ohno R; Munechika T; Matsumoto Y; Takahashi H; Aisu N; Kojima D; Yoshimatsu G; Hasegawa S; Kobayashi H; Sugihara K
    Eur J Surg Oncol; 2022 Dec; 48(12):2467-2474. PubMed ID: 35752499
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Effect of KRAS codon 12 or 13 mutations on survival with trifluridine/tipiracil in pretreated metastatic colorectal cancer: a meta-analysis.
    Yoshino T; Van Cutsem E; Li J; Shen L; Kim TW; Sriuranpong V; Xuereb L; Aubel P; Fougeray R; Cattan V; Amellal N; Ohtsu A; Mayer RJ
    ESMO Open; 2022 Jun; 7(3):100511. PubMed ID: 35688062
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Impact of preoperative prognostic nutritional index levels on morbidity in colorectal cancer surgery.
    Senger AS; Dincer M; Uzun O; Gulmez S; Avan D; Ofluoglu CB; Polat E; Duman M
    Ann Ital Chir; 2022; 92():422-426. PubMed ID: 35190499
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Analysis of related factors of prognosis after surgical treatment of patients with non-metastatic colorectal cancer and construction of a normagram prediction model].
    Liu SX; Zhang L; Shi YK; Han XH
    Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):167-172. PubMed ID: 35184461
    [No Abstract]    [Full Text] [Related]  

  • 12. Risk factors for surgical site infection and association of surgical site infection with survival of lower rectal cancer patients without clinical lateral pelvic lymph node metastasis (clinical Stage II/III): Analysis of data from JCOG0212.
    Katsumata K; Enomoto M; Ishizaki T; Fujita S; Kanemitsu Y; Ito M; Shiomi A; Komori K; Ohue M; Ota M; Akazai Y; Shiozawa M; Yamaguchi T; Bando H; Sekimoto M; Kobatake T; Machida R; Akasu T; Moriya Y;
    Clin Exp Metastasis; 2021 Oct; 38(5):459-466. PubMed ID: 34406563
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Identification of DNA methylation biomarkers for risk of liver metastasis in early-stage colorectal cancer.
    Li W; Guo L; Tang W; Ma Y; Wang X; Shao Y; Zhao H; Ying J
    Clin Epigenetics; 2021 Jun; 13(1):126. PubMed ID: 34108011
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. prognosis Comparisons of Laparoscopy versus Open Surgery for Rectal cancer Patients after Preoperative Chemoradiotherapy: A Meta-Analysis.
    Niu JW; Ning W; Liu ZZ; Pei DP; Meng FQ; Zhou L
    Oncol Res Treat; 2021; 44(5):261-268. PubMed ID: 33910201
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Clinical Implications of cancer Stem Cell Markers and ABC Transporters as a Predictor of prognosis in colorectal cancer Patients.
    Kim BH; Oh HK; Kim DW; Kang SB; Choi Y; Shin E
    Anticancer Res; 2020 Aug; 40(8):4481-4489. PubMed ID: 32727778
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Identification of Four Pathological Stage-Relevant Genes in Association with Progression and prognosis in Clear Cell Renal Cell Carcinoma by Integrated Bioinformatics Analysis.
    Xu D; Xu Y; Lv Y; Wu F; Liu Y; Zhu M; Chen D; Bai B
    Biomed Res Int; 2020; 2020():2137319. PubMed ID: 32309427
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The Clinicopathological and Survival Profiles Comparison Across Primary Sites in Acral Melanoma.
    Wei X; Wu D; Li H; Zhang R; Chen Y; Yao H; Chi Z; Sheng X; Cui C; Bai X; Qi Z; Li K; Lan S; Chen L; Guo R; Yao X; Mao L; Lian B; Kong Y; Dai J; Tang B; Yan X; Wang X; Li S; Zhou L; Balch CM; Si L; Guo J
    Ann Surg Oncol; 2020 Sep; 27(9):3478-3485. PubMed ID: 32253677
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Identification of potential hub genes via bioinformatics analysis combined with experimental verification in colorectal cancer.
    Zhou H; Yang Z; Yue J; Chen Y; Chen T; Mu T; Liu H; Bi X
    Mol Carcinog; 2020 Apr; 59(4):425-438. PubMed ID: 32064687
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Clinical impact of first-line bevacizumab plus chemotherapy in metastatic colorectal cancer of mucinous histology: a multicenter, retrospective analysis on 685 patients.
    Catalano V; Bergamo F; Cremolini C; Vincenzi B; Negri F; Giordani P; Alessandroni P; Intini R; Stragliotto S; Rossini D; Borelli B; Santini D; Sarti D; Rocchi MBL; Lonardi S; Falcone A; Zagonel V; Mattioli R; Graziano F
    J Cancer Res Clin Oncol; 2020 Feb; 146(2):493-501. PubMed ID: 31691872
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Anal adenocarcinoma: Treatment outcomes and trends in a rare disease entity.
    Wegner RE; White RJ; Hasan S; Raj M; Monga D; Finley G; Kirichenko AV; McCormick J
    Cancer Med; 2019 Jul; 8(8):3855-3863. PubMed ID: 31173487
    [TBL] [Abstract] [Full Text] [Related]  


    of 2.